Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease

Journal of Cystic Fibrosis

Volumn 8, Issue 6, 2009, Pages 392-399

  Witters, Peter ^a   De Boeck, Kris ^a   Dupont, Lieven ^a   Proesmans, Marijke ^a   Vermeulen, François ^a   Servaes, Roger ^a   Verslype, Chris ^a   Laleman, Wim ^a   Nevens, Frederik ^a   Hoffman, Ilse ^a   Cassiman, David ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Cystic fibrosis; Cystic fibrosis associated liver disease; Fibroscan; Screening and diagnosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE;

ADOLESCENT; ADULT; AGE; ARTICLE; BIOCHEMISTRY; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ECHOGRAPHY; ELASTOGRAPHY; FEMALE; HEPATOMEGALY; HUMAN; INTERMETHOD COMPARISON; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; QUANTITATIVE ANALYSIS; SCHOOL CHILD; SPLENOMEGALY;

ADOLESCENT; BIOPSY; CHILD; CYSTIC FIBROSIS; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; LIVER DISEASES; MALE; MASS SCREENING; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; ROC CURVE; ULTRASONOGRAPHY;

EID: 70449688132     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2009.08.001     Document Type: Article

References (26)

1. Lamireau T., Monnereau S., Martin S., Marcotte J., Winnock M., and Alvarez F. Epidemiology of liver disease in cystic fibrosis: a longitudinal study. J Hepatol (2004) 920-925
2. Lindblad A., Glaumann H., and Strandvik B. Natural history of liver disease in cystic fibrosis. Hepatology (1999) 1151-1158
3. Sokol R.J., and Durie P.R. Recommendations for management of liver and biliary tract disease in cystic fibrosis. cystic fibrosis foundation hepatobiliary disease consensus group. J Pediatr Gastroenterol Nutr (1999) S1-S13
4. Colombo C., Battezzati P.M., Crosignani A., Morabito A., Costantini D., Padoan R., et al. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome. Hepatology (2002) 1374-1382
5. Vawter G.F., and Shwachman H. Cystic fibrosis in adults: an autopsy study. Pathol Annu (1979) 357-382
6. Wilschanski M., Rivlin J., Cohen S., Augarten A., Blau H., Aviram M., et al. Clinical and genetic risk factors for cystic fibrosis-related liver disease. Pediatrics (1999) 52-57
7. Lenaerts C., Lapierre C., Patriquin H., Bureau N., Lepage G., Harel F., et al. Surveillance for cystic fibrosis-associated hepatobiliary disease: early ultrasound changes and predisposing factors. J Pediatr (2003) 343-350
8. Slieker M.G., Deckers-Kocken J.M., Uiterwaal C.S.P.M., van der Ent C.K., and Houwen R.H.J. Risk factors for the development of cystic fibrosis related liver disease. Hepatology (2003) 775-776 author reply 776-7
9. Corbett K., Kelleher S., Rowland M., Daly L., Drumm B., Canny G., et al. Cystic fibrosis-associated liver disease: a population-based study. J Pediatr (2004) 327-332
10. Bravo A.A., Sheth S.G., and Chopra S. Liver biopsy. N Engl J Med (2001) 495-500
11. Sandrin L., Fourquet B., Hasquenoph J., Yon S., Fournier C., Mal F., et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol (2003) 1705-1713
12. Friedrich-Rust M., Ong M., Martens S., Sarrazin C., Bojunga J., Zeuzem S., et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology (2008) 960-974
13. de Lédinghen V., Le Bail B., Rebouissoux L., Fournier C., Foucher J., Miette V., et al. Liver stiffness measurement in children using fibroscan: feasibility study and comparison with fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr (2007) 443-450
14. Friedrich-Rust M., Koch C., Rentzsch A., Sarrazin C., Schwarz P., Herrmann E., et al. Noninvasive assessment of liver fibrosis in patients with fontan circulation using transient elastography and biochemical fibrosis markers. J Thorac Cardiovasc Surg (2008) 560-567
15. Nobili V., Vizzutti F., Arena U., Abraldes J.G., Marra F., Pietrobattista A., et al. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology (2008) 442-448
16. Lee T.W.R., Brownlee K.G., Conway S.P., Denton M., and Littlewood J.M. Evaluation of a new definition for chronic pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros (2003) 29-34
17. Wai C., Greenson J.K., Fontana R.J., Kalbfleisch J.D., Marrero J.A., Conjeevaram H.S., et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis c. Hepatology (2003) 518-526
18. Williams S.G., Evanson J.E., Barrett N., Hodson M.E., Boultbee J.E., and Westaby D. An ultrasound scoring system for the diagnosis of liver disease in cystic fibrosis. J Hepatol (1995) 513-521
19. Narkewicz M.R. Markers of cystic fibrosis-associated liver disease. J Pediatr Gastroenterol Nutr (2001) 421-422
20. Potter C.J., Fishbein M., Hammond S., McCoy K., and Qualman S. Can the histologic changes of cystic fibrosis-associated hepatobiliary disease be predicted by clinical criteria?. J Pediatr Gastroenterol Nutr (1997) 32-36
21. Boursier J., Konaté A., Gorea G., Reaud S., Quemener E., Oberti F., et al. Reproducibility of liver stiffness measurement by ultrasonographic elastometry. Clin Gastroenterol Hepatol (2008) 1263-1269
22. Boursier J., Konate A., Guilluy M., Gorea G., Sawadogo A., Quemener E., et al. Learning curve and interobserver reproducibility evaluation of liver stiffness measurement by transient elastography. Eur J Gastroenterol Hepatol (2008) 693-701
23. Wilschanski M., Fisher D., Hadas-Halperin I., Picard E., Faber J., Goldberg S., et al. Findings on routine abdominal ultrasonography in cystic fibrosis patients. J Pediatr Gastroenterol Nutr (1999) 182-185
24. Millonig G., Reimann F.M., Friedrich S., Fonouni H., Mehrabi A., Büchler M.W., et al. Extrahepatic cholestasis increases liver stiffness (fibroscan) irrespective of fibrosis. Hepatology (2008) 1718-1723
25. Colombo C., Russo M.C., Zazzeron L., and Romano G. Liver disease in cystic fibrosis. J Pediatr Gastroenterol Nutr (2006) S49-S55
26. Cheng K., Ashby D., and Smyth R. Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database Syst Rev (2000) CD000222